National Guideline Clearinghouse | American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis.
December 24, 2012
Guideline Title
American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis.
Bibliographic Source(s)
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA, AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012 Mar-Apr;18(Suppl 1):1-78. [606 references] PubMed |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: American Association of Clinical Endocrinologists. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract 2000 Mar-Apr;6(2):162-213.
This guideline updates a previous version: American Association of Clinical Endocrinologists. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract 2000 Mar-Apr;6(2):162-213.
Endocr Pract. 2012 Mar-Apr;18 Suppl 1:1-78.
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis.
- PMID:
- 22522068
- [PubMed - indexed for MEDLINE]
- American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary. [Endocr Pract. 2012]
- Controversies in dyslipidaemia management. [Atherosclerosis. 2012]
- Review Management of dyslipidemia in the elderly population. [Ther Adv Cardiovasc Dis. 2010]
- Review Treatment of dyslipidemia in children and adolescents. [Curr Cardiol Rep. 2005]
- Review Prevention of atherosclerosis and drug treatment of high-risk lipid abnormalities in children and adolescents. [J Pediatr (Rio J). 2009]
No hay comentarios:
Publicar un comentario